CDKN2B and central nervous system cancer: Meanwhile, higher levels of RhoA, another ceRNA member of CDKN2B and a downstream factor in TGF-β/MAPK signaling pathway, can significantly promote glioma cell proliferation and migration (Wan and Too, 2010; Shabtay-Orbach et al., 2015).